Ovarian cancer has long been associated with a striking preference for the omentum, a fatty apron of tissue that hangs from the stomach and covers much of the abdominal organs. When ovarian cancer cells escape the primary tumor, they frequently travel through the peritoneal cavity and establish secondary growths on this organ. The omentum has therefore been viewed not only as a passive landing site but also as a nutrient-rich environment capable of supporting tumor expansion. A new study published in Nature Communications now challenges one of the most familiar assumptions about this process: that mature fat cells are required for ovarian cancer to grow in the omentum.
The research, led by R.L. Mintz, J. Han, E.G. Butka and colleagues, reports that peritoneal ovarian cancer growth in the omentum can proceed independently of mature adipocytes. Adipocytes are the specialized cells responsible for storing energy as lipid droplets and are the dominant cellular component of most visible body fat. Because ovarian tumors often invade adipose-rich tissues and can interact metabolically with fat cells, mature adipocytes have attracted intense attention as possible providers of fuel and growth signals. The new finding suggests that the relationship between ovarian cancer and the omentum is more complex than a simple dependence on nearby fat cells.
The omentum is biologically active tissue rather than an inert layer of abdominal fat. It contains blood vessels, connective-tissue cells, immune cells, extracellular matrix and populations of progenitor cells that can change their behavior in response to injury or inflammation. It also functions as an immunological surveillance site, helping detect material that enters the peritoneal cavity. This combination of vascular, immune and structural features may make the omentum a particularly favorable environment for disseminated cancer cells. The study’s central conclusion redirects attention toward these broader components of the tissue and away from mature adipocytes as the sole or indispensable drivers of tumor growth.
The distinction is important because cancer cells can obtain support from adipose tissue in several different ways. Mature adipocytes may release fatty acids, cytokines and other signaling molecules, while neighboring stromal cells can remodel the extracellular matrix and create physical pathways for invasion. Blood vessels can supply oxygen and nutrients, and immune cells can either attack tumor cells or, under certain conditions, become reprogrammed to promote their survival. A tumor may also alter the local tissue before it arrives, creating what researchers call a pre-metastatic niche. If mature adipocytes are not essential, the decisive signals may come from this wider cellular network rather than from fat storage cells themselves.
The finding also speaks to the biology of peritoneal metastasis, the process by which cancer cells spread across the lining of the abdominal cavity. In ovarian cancer, tumor cells can detach from the original mass, circulate in peritoneal fluid or attach directly to exposed surfaces. Successful colonization requires more than physical adhesion. Cancer cells must resist mechanical stress, evade immune destruction, secure nutrients and establish a blood supply. They must also adapt to a new biochemical environment. The ability of ovarian cancer to grow without mature adipocytes indicates that the omentum may provide these advantages through multiple coordinated mechanisms.
This result does not mean that adipose tissue is irrelevant to ovarian cancer. Instead, it separates the effects of mature adipocytes from the effects of the tissue surrounding them. Fat cells can still influence inflammation, metabolism and signaling even if tumors do not require them as direct growth partners. Moreover, adipose tissue contains precursor cells that can differentiate into adipocytes, as well as fibroblasts, endothelial cells and immune populations. Those cells may respond differently to cancer than fully mature adipocytes do. Treating “fat” as a single biological entity can therefore conceal critical differences between its constituent cell types.
The study may have significant implications for how researchers search for therapies against metastatic ovarian cancer. Strategies designed solely to block the exchange of lipids between adipocytes and tumor cells could miss alternative survival routes. If cancer growth depends more heavily on vascular remodeling, extracellular-matrix changes, immune suppression or signals from adipocyte precursor cells, those pathways may represent more effective targets. The findings also emphasize the importance of identifying which cells are functionally essential within a metastatic niche. A therapy that disrupts a supportive interaction without damaging normal tissue could potentially be more precise than treatments aimed broadly at the entire omentum.
For patients, the work is best understood as a step toward a more detailed map of ovarian cancer spread rather than as an immediate change in clinical treatment. Ovarian cancer remains difficult to detect early and is often diagnosed after it has disseminated within the abdomen. Although surgery, chemotherapy, targeted drugs and newer immune-based approaches can provide meaningful benefits, recurrence remains a major challenge. Understanding how tumor cells survive in specific anatomical sites could help scientists develop treatments that prevent metastatic colonies from becoming established or make them more vulnerable once they form.
The broader message is that cancer biology often resists simple explanations. A tumor may appear to thrive in a fatty organ without depending on its most obvious cellular component. By showing that ovarian cancer growth in the omentum proceeds independently of mature adipocytes, Mintz and colleagues highlight the importance of studying metastatic tissues as living ecosystems. The next phase of research will need to determine which omental cells and molecular pathways compensate for the absence of mature fat cells, and whether those mechanisms can be blocked. That answer could reveal why the omentum is such a favored destination for ovarian cancer—and how its welcome might eventually be withdrawn.
Subject of Research: Peritoneal ovarian cancer growth in the omentum and its independence from mature adipocytes
Article Title: Peritoneal ovarian cancer growth in the omentum proceeds independently of mature adipocytes.
Article References: Mintz, R.L., Han, J., Butka, E.G. et al. “Peritoneal ovarian cancer growth in the omentum proceeds independently of mature adipocytes.” Nature Communications (2026). https://doi.org/10.1038/s41467-026-76471-x
Image Credits: AI Generated
DOI: 10.1038/s41467-026-76471-x
Keywords: ovarian cancer, peritoneal metastasis, omentum, mature adipocytes, adipose tissue, tumor microenvironment, cancer biology, metastasis
